Immobilized nucleic acid mismatch recognition protein as well as immobilization method and application thereof
By combining MutS protein with biotin and magnetic beads modified with streptavidin, the immobilized nucleic acid mismatch recognition protein was prepared, which solved the problems of high cost and cumbersome operation of existing DNA synthesis error correction techniques, and achieved high efficiency DNA error correction effect.
Patent Information
- Application Number
- CN202411172404.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-23
- Publication Date
- 2024-11-19
AI Technical Summary
The existing DNA synthesis error correction technology has problems such as high cost, cumbersome operation, unstable error correction effect and incomplete error correction system, which affects the fidelity and synthesis efficiency of DNA products.
Immobilized nucleic acid mismatch recognition protein MutS is prepared by mixing the nucleic acid mismatch recognition protein MutS with biotin and co-incubating with magnetic beads modified with streptavidin, which can capture heterologous double-strands under mild conditions DNA, initiates the DNA error correction and repair process.
It significantly improves the error correction efficiency of heterologous double-stranded DNA, improves the stability and efficiency of DNA error correction, and reduces cost and operational complexity.
Smart Images

Figure CN118978601A_ABST
Abstract
Description
Technical Field
[0001] The present disclosure relates to the field of biotechnology, and in particular to an immobilized nucleic acid mismatch recognition protein and an immobilization method and application thereof. Background Art
[0002] As the underlying technology of synthetic biology, de novo DNA synthesis technology has significant advantages such as flexible design, no restrictions on natural templates, and scalable production. However, in the process of artificial synthesis and assembly of gene fragments, incorrect bases are often introduced, resulting in poor fidelity of DNA products, which in turn increases the difficulty of obtaining correct products and the sequencing cost, seriously affecting the synthesis efficiency.
[0003] Mismatch recognition protein (MutS) is a promoter in the DNA repair system of organisms. It can recognize and bind mismatched bases and trigger the subsequent repair process, playing a key role in the DNA repair system. In synthetic biology, DNA error correction technology based on MutS can effectively reduce the error rate of sequence synthesis, reduce manpower, time and economic costs. Immobilized MutS error correction has the advantages of high throughput, easy automation and low cost. However, the existing DNA synthesis error correction technology has problems such as high cost, cumbersome operation, unstable error correction effect and imperfect error correction system. Therefore, it is of great significance to develop a DNA error correction method based on immobilized MutS. Summary of the invention
[0004] The present disclosure provides an immobilized nucleic acid mismatch recognition protein and a method and application of immobilizing the protein, so as to at least solve the above technical problems existing in the prior art.
[0005] According to a first aspect of the present disclosure, a method for fixing a nucleic acid mismatch recognition protein is provided, comprising the following steps:
[0006] S1: mixing the nucleic acid mismatch recognition protein (MutS) with biotin to obtain a biotin-modified nucleic acid mismatch recognition protein;
[0007] S2: co-incubating the biotin-modified NAMR protein with magnetic beads modified with streptavidin to obtain immobilized NAMR protein.
[0008] In one embodiment, in step S1, the nucleic acid mismatch recognition protein, the biotin and the biotin coupling solution are mixed, and the biotin-modified nucleic acid mismatch recognition protein is obtained after reacting for 2 to 2.5 hours.
[0009] In one embodiment, the mass ratio of the nucleic acid mismatch recognition protein to the magnetic beads modified with streptavidin is 1:50-150.
[0010] In a preferred embodiment, the mass ratio of the nucleic acid mismatch recognition protein to the magnetic beads modified with streptavidin is 1:150.
[0011] In one embodiment, in step S2, before the magnetic beads modified with streptavidin are co-incubated with the biotin-modified nucleic acid mismatch recognition protein, a washing step is further included: placing the magnetic beads modified with streptavidin on a magnetic rack for separation for 1 to 1.5 minutes, and removing the supernatant; subsequently, 1×TBS is added to resuspend and wash the magnetic beads, and the beads are placed on a magnetic rack for separation for 10 to 15 seconds, and the washing is repeated 4 times; finally, the magnetic beads are resuspended in washing buffer.
[0012] Specifically, the washing buffer includes PBS (pH 7.4) and 0.05% Tween-20.
[0013] In one embodiment, the co-incubation conditions in step S2 are: temperature 25-28° C., rotation speed 300-350 rpm, and time 1-1.5 h.
[0014] In a preferred embodiment, the co-incubation conditions in step S2 are: temperature 25° C., rotation speed 300 rpm, and time 1 h.
[0015] According to a second aspect of the present disclosure, provided is an immobilized nucleic acid mismatch recognition protein obtained according to the above-mentioned immobilization method.
[0016] According to a third aspect of the present disclosure, there is provided a use of the above-mentioned immobilized nucleic acid mismatch recognition protein in DNA error correction.
[0017] According to the fourth aspect of the present disclosure, a method for DNA error correction is provided, comprising the following steps: mixing the above-mentioned immobilized nucleic acid mismatch recognition protein with the DNA molecule to be corrected, so that the immobilized nucleic acid mismatch recognition protein recognizes and binds to the mismatched bases in the DNA molecule to initiate DNA mismatch repair.
[0018] In one embodiment, the mass ratio of the immobilized nucleic acid mismatch recognition protein to the DNA molecule to be corrected is 2-6:1.
[0019] According to a fifth aspect of the present disclosure, a product for DNA error correction is provided, the product comprising the above-mentioned immobilized nucleic acid mismatch recognition protein.
[0020] According to an implementable embodiment of the present disclosure, at least the following beneficial effects are achieved:
[0021] The immobilized nucleic acid mismatch recognition protein prepared by the present invention has high stability, can capture heteroduplex DNA under mild conditions, and significantly improves the error correction efficiency of heteroduplex DNA.
[0022] It should be understood that the content described in this section is not intended to identify the key or important features of the embodiments of the present disclosure, nor is it intended to limit the scope of the present disclosure. Other features of the present disclosure will become easily understood through the following description. BRIEF DESCRIPTION OF THE DRAWINGS
[0023] The above and other objects, features and advantages of the exemplary embodiments of the present disclosure will become readily understood by reading the detailed description below with reference to the accompanying drawings. In the accompanying drawings, several embodiments of the present disclosure are shown in an exemplary and non-limiting manner, in which:
[0024] In the drawings, the same or corresponding reference numerals represent the same or corresponding parts.
[0025] Figure 1 The gel electrophoresis result diagram in Example 1 of the present disclosure is shown; wherein, 1-MutS protein; 2-biotin-modified MutS protein; 3-immobilized MutS protein;
[0026] Figure 2 The gel electrophoresis result diagram in Example 2 of the present disclosure is shown; wherein, 1-biotin-modified MutS protein; 2-magnetic beads modified with streptavidin+Washing bufferⅡ; 3-magnetic beads modified with streptavidin+SA binding buffer; 4-immobilized MutS protein+Washing bufferⅡ; 5-immobilized MutS protein+SA binding buffer;
[0027] Figure 3 The gel electrophoresis result diagram in Example 3 of the present disclosure is shown; wherein, 1-MutS protein; 2-immobilized MutS protein, magnetic beads modified with streptavidin are 50 μg; 3-immobilized MutS protein, magnetic beads modified with streptavidin are 100 μg; 4-immobilized MutS protein, magnetic beads modified with streptavidin are 150 μg;
[0028] Figure 4 The result diagram of the repair amplification product bands after error correction of the immobilized MutS protein is shown in Example 4 of the present disclosure by agarose gel electrophoresis. DETAILED DESCRIPTION
[0029] In order to make the purpose, features, and advantages of the present disclosure more obvious and easy to understand, the technical solutions in the embodiments of the present disclosure will be clearly and completely described below in conjunction with the drawings in the embodiments of the present disclosure. Obviously, the described embodiments are only part of the embodiments of the present disclosure, not all of the embodiments. Based on the embodiments in the present disclosure, all other embodiments obtained by those skilled in the art without creative work are within the scope of protection of the present disclosure.
[0030] Example 1
[0031] In this example, immobilized MutS protein was prepared, and the specific process was as follows:
[0032] (1) 1 μg of MutS protein, 2 μL of biotin coupling solution and 2 μL of dissolved activated biotin (10 mg / mL) were mixed and slowly reacted on a rotary mixer at room temperature for 2 h, the temperature was 25°C, and the rotation speed was 300 rpm to obtain biotin-modified MutS protein.
[0033] (2) Take 5 μL of the mixed magnetic beads modified with streptavidin and place them in a 200 μL centrifuge tube for later use. Place them on a magnetic stand for separation for 1 min before use and remove the supernatant. Then add 50 μL of 1×TBS and gently blow to resuspend and wash the magnetic beads modified with streptavidin. Place them on a magnetic stand for separation for 10 s, remove the supernatant, and repeat the washing 4 times. Take 15 μL of Washing buffer Ⅱ (PBS (pH 7.4), 0.05% Tween-20) to resuspend the magnetic beads modified with streptavidin.
[0034] (3) 5 μL of biotin-modified MutS protein was incubated with the washed magnetic beads modified with streptavidin at 25° C. and 300 rpm for 1 h to obtain immobilized MutS protein.
[0035] The biotin-modified MutS protein and the immobilized MutS protein were subjected to SDS-PAGE. Figure 1 shown. Figure 1 It showed that the MutS protein was successfully modified with biotin, and the biotin-modified MutS protein was successfully bound to the magnetic beads modified with streptavidin.
[0036] Example 2
[0037] This example verifies the effect of different buffer systems on the binding of MutS protein to magnetic beads modified with streptavidin.
[0038] 5 μL of biotin-modified MutS protein was incubated with the washed magnetic beads modified with streptavidin in 15 μL of Washing buffer II or 15 μL of SA binding buffer (100 mM NaCl, 20 mM Tris-HCl, 0.1 mM EDTA, 0.1% Tween-20) at 25°C, 300 rpm and 1 h.
[0039] The binding effect was verified by SDS-PAGE. Figure 2 shown. Figure 2 The results show that both buffers will not affect the stability of the magnetic beads modified with streptavidin, and have no obvious effect on the binding efficiency of the MutS protein with the magnetic beads modified with streptavidin, and both buffers can successfully bind the MutS protein to the magnetic beads modified with streptavidin.
[0040] Example 3
[0041] This example verifies the optimal binding ratio between the MutS protein and the magnetic beads modified with streptavidin.
[0042] 5 μL of biotin-modified MutS protein was incubated with 50 μg, 100 μg, and 150 μg of washed magnetic beads modified with streptavidin in 15 μL of Washing buffer Ⅱ at 25°C, 300 rpm, and 1 h.
[0043] The binding effect was verified by SDS-PAGE, and the results were as follows Figure 3 shown. Figure 3 It was shown that as the amount of magnetic beads modified with streptavidin increased, the binding efficiency of MutS protein to the magnetic beads modified with streptavidin also increased, and the optimal binding mass ratio was 1:150, which could fix the MutS protein on the magnetic beads with maximum efficiency.
[0044] Example 4
[0045] This example uses the immobilized MutS protein prepared in Example 1 for DNA error correction.
[0046] (1) Using a 522 bp synthetic DNA sequence as a template, the immobilized MutS protein was co-incubated with 2 μL of the DNA sequence template in a binding buffer (20 mM Tris-HCl, pH 8.0, 100 mM KCl, 5 mM MgCl2) with a total volume of 40 μL, a rotation speed of 800 rpm, and temperatures of 20°C, 25°C, and 30°C (wherein the amount of immobilized MutS protein was 10 μL and the incubation time was 30 min); the incubation times were 20 min, 30 min, and 40 min (wherein the amount of immobilized MutS protein was 10 μL and the temperature was 25°C); the amounts of immobilized MutS protein were 5 μL, 10 μL, and 15 μL (wherein the temperature was 25°C and the incubation time was 30 min).
[0047] (2) After the error correction reaction is completed, the PCR tube is concentrated on a magnetic rack for 5 minutes, and the supernatant is retained. The supernatant is used as a template for PCR repair amplification. The reaction system is
[0048] 2×Phanta Max Master Mix, 12.5μL;
[0049] Template, 2 μL;
[0050] Primer F (10 μM), 1 μL;
[0051] Primer R (10 μM), 1 μL;
[0052] ddH2O, 8.5 μL.
[0053] Reaction conditions: 95°C, 30s;
[0054] 95℃, 15s; 55℃, 15s; 72℃, 40s; 30 cycles in total;
[0055] 72℃, 5min;
[0056] This was then verified using agarose gel electrophoresis.
[0057] (3) Agarose gel electrophoresis results are shown in the figure below. Figure 4 As shown, Figure 4 The results showed that the repair amplification product bands were clear and correct as identified by agarose gel electrophoresis, and the error correction of the immobilized MutS protein had no effect on the amplification of the DNA fragments.
[0058] It should be understood that the various forms of processes shown above can be used to reorder, add or delete steps. For example, the steps recorded in this disclosure can be executed in parallel, sequentially or in different orders, as long as the desired results of the technical solution of this disclosure can be achieved, and this document is not limited here.
[0059] In addition, the terms "first" and "second" are used for descriptive purposes only and should not be understood as indicating or implying relative importance or implicitly indicating the number of technical features indicated. Thus, a feature defined as "first" or "second" may explicitly or implicitly include at least one of the features. In the description of the present disclosure, the meaning of "plurality" is two or more, unless otherwise clearly and specifically defined.
[0060] The above is only a specific embodiment of the present disclosure, but the protection scope of the present disclosure is not limited thereto. Any person skilled in the art who is familiar with the technical field can easily think of changes or substitutions within the technical scope disclosed in the present disclosure, which should be included in the protection scope of the present disclosure. Therefore, the protection scope of the present disclosure should be based on the protection scope of the claims.
Claims
1. A method for fixing a nucleic acid mismatch recognition protein, characterized in that: The following steps are involved: S1: mixing the nucleic acid mismatch recognition protein with biotin to obtain a biotin-modified nucleic acid mismatch recognition protein; S2: co-incubating the biotin-modified NAMR protein with magnetic beads modified with streptavidin to obtain immobilized NAMR protein.
2. The fixing method according to claim 1, characterized in that: Step S1: Mix the nucleic acid mismatch recognition protein, the biotin and the biotin coupling solution, and react for 2 to 2.5 hours to obtain the biotin-modified nucleic acid mismatch recognition protein.
3. The fixing method according to claim 1, characterized in that: The mass ratio of the nucleic acid mismatch recognition protein to the magnetic beads modified with streptavidin is 1:50-150.
4. The fixing method according to claim 1, characterized in that: The co-incubation conditions in step S2 are: temperature 25-28° C., rotation speed 300-350 rpm, and time 1-1.5 h. 5 . The immobilized nucleic acid mismatch recognition protein obtained by the immobilization method according to claim 1 .
6. Use of the immobilized nucleic acid mismatch recognition protein according to claim 5 in DNA error correction.
7. A method for DNA error correction, characterized in that: The method comprises the following steps: mixing the immobilized nucleic acid mismatch recognition protein according to claim 5 with a DNA molecule to be corrected, so that the immobilized nucleic acid mismatch recognition protein recognizes and binds to the mismatched bases in the DNA molecule to initiate DNA mismatch repair.
8. The method according to claim 7, characterized in that The mass ratio of the immobilized nucleic acid mismatch recognition protein to the DNA molecule to be corrected is 2-6:
1.
9. A product for DNA error correction, characterized in that: The product comprises the immobilized nucleic acid mismatch recognition protein according to claim 5.
